Provided by Tiger Fintech (Singapore) Pte. Ltd.

10x Genomics, Inc.

7.68
+0.17002.26%
Post-market: 7.58-0.1000-1.30%18:35 EDT
Volume:6.99M
Turnover:52.57M
Market Cap:939.28M
PE:-5.07
High:7.70
Open:7.39
Low:7.25
Close:7.51
Loading ...

10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025

PR Newswire
·
15 Apr

Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk

Dow Jones
·
15 Apr

BofA Securities Cuts Price Target on 10x Genomics to $12 From $16, Neutral Rating Maintained

MT Newswires Live
·
14 Apr

AI Biotech Stocks Shined. Recursion Soared 20% And Absci Surged 13%

Tiger Newspress
·
11 Apr

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
10 Apr

PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know

StockStory
·
10 Apr

BUZZ-Impact of NIH job cuts "better than feared" for life sciences firms, Leerink says

Reuters
·
27 Mar

We Think 10x Genomics (NASDAQ:TXG) Can Easily Afford To Drive Business Growth

Simply Wall St.
·
27 Mar

2 Reasons to Sell TXG and 1 Stock to Buy Instead

StockStory
·
11 Mar

AI Biotech Stocks Shined, With Ginkgo Up 8%, Recursion And Absci Up 4%, Crispr Up 3%

Tiger Newspress
·
05 Mar

10x Genomics Is Maintained at Buy by Citigroup

Dow Jones
·
05 Mar

10x Genomics price target lowered to $15 from $20 at Citi

TIPRANKS
·
04 Mar

10x Genomics: Co's Litigation Against Parse's Gene Expression Products Remains Ongoing

THOMSON REUTERS
·
04 Mar

10x Genomics Secures Injunction Against Parse Biosciences' Planned Atac Products

THOMSON REUTERS
·
04 Mar

10x Genomics secures injunction against Parse Biosciences’ planned ATAC products

TIPRANKS
·
04 Mar

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

PR Newswire
·
04 Mar

1 Stock Under $50 on Our Watchlist and 2 to Ignore

StockStory
·
03 Mar

AI Biotech Stocks Tumbled, with HIMS Plunging 17% and TEM Slumping 15%

Tiger Newspress
·
25 Feb

AI Biotech Stocks Shined, with Recursion and Tempus Jumping 5%

Tiger Newspress
·
24 Feb

10x Genomics unveils roadmap at AGBT general meeting

TIPRANKS
·
24 Feb